ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,849.72
      -1.76%
      US Tech 100
      19,912.40
      -2.04%
      Dow Jones
      43,191.24
      -1.48%
      Brent Oil
      71.175
      -0.32%
      Bitcoin
      84,102.97
      -2.31%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Biodesix Inc (BDSX) Quote

      Biodesix Inc

      Biodesix Inc (BDSX)

      NASDAQ
      0.713
      -0.08
      (-10.09%)
      Closed March 03 4:00PM
      Delayed by 15 minutes
      0.8798
      0.1668
      (23.39%)
      After Hours: 7:56PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.8798
      Bid
      0.83
      Ask
      0.8799
      Volume
      439,558
      0.7002 Day's Range 0.85
      0.7004 52 Week Range 2.04
      Market Cap
      127.982M
      Previous Close
      0.793
      Open
      0.83
      Last Trade
      28
      @
      0.8799
      Last Trade Time
      Financial Volume
      $ 332,358
      VWAP
      0.756119
      Average Volume (3m)
      327,791
      Shares Outstanding
      145,467,295
      Dividend Yield
      -
      PE Ratio
      -1.95
      Earnings Per Share (EPS)
      -0.36
      Revenue
      49.09M
      Net Profit
      -52.15M

      About Biodesix Inc

      Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Show more

      Sector
      Medical Laboratories
      Industry
      Medical Laboratories
      Website
      www.biodesix.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Biodesix Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker BDSX. The last closing price for Biodesix was $0.79. Over the last year, Biodesix shares have traded in a share price range of $ 0.7004 to $ 2.04.

      Biodesix currently has 145,467,295 shares outstanding. The market capitalization of Biodesix is $115.36 million. Biodesix has a price to earnings ratio (PE ratio) of -1.95.

      Ask ADVFN Intelligence (AI)

      BDSX Latest News

      More News

      Form 8-K - Current report
      Edgar (US Regulatory)
      7 hours ago
      BDSX (-10.09%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 26 2025
      BDSX (-10.09%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 26 2025
      BDSX (-10.09%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 26 2025
      BDSX (-10.09%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 26 2025
      BDSX (-10.09%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 26 2025
      BDSX (-10.09%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0102-1.146067415730.890.930.70041894690.81383638CS
      4-0.1202-12.0211.080.70042740290.95455692CS
      12-0.4502-33.84962406021.331.610.70043277911.15607716CS
      26-1.1002-55.56565656571.9820.70043646761.30374311CS
      52-0.7202-45.01251.62.040.70042519351.36581542CS
      156-1.5402-63.64462809922.4230.70042039751.58922759CS
      260-12.7102-93.526122148613.5931.990.70041836944.0443389CS

      BDSX - Frequently Asked Questions (FAQ)

      What is the current Biodesix share price?
      The current share price of Biodesix is $ 0.8798
      How many Biodesix shares are in issue?
      Biodesix has 145,467,295 shares in issue
      What is the market cap of Biodesix?
      The market capitalisation of Biodesix is USD 115.36M
      What is the 1 year trading range for Biodesix share price?
      Biodesix has traded in the range of $ 0.7004 to $ 2.04 during the past year
      What is the PE ratio of Biodesix?
      The price to earnings ratio of Biodesix is -1.95
      What is the cash to sales ratio of Biodesix?
      The cash to sales ratio of Biodesix is 2.07
      What is the reporting currency for Biodesix?
      Biodesix reports financial results in USD
      What is the latest annual turnover for Biodesix?
      The latest annual turnover of Biodesix is USD 49.09M
      What is the latest annual profit for Biodesix?
      The latest annual profit of Biodesix is USD -52.15M
      What is the registered address of Biodesix?
      The registered address for Biodesix is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Biodesix website address?
      The website address for Biodesix is www.biodesix.com
      Which industry sector does Biodesix operate in?
      Biodesix operates in the MEDICAL LABORATORIES sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ACONAclarion Inc
      $ 7.511
      (124.21%)
      		89.21M
      BTOGBit Origin Ltd
      $ 0.3209
      (76.32%)
      		291.2M
      BTAIBioXcel Therapeutics Inc
      $ 3.73
      (72.69%)
      		146.85M
      CLROClearOne Inc
      $ 0.78
      (50.87%)
      		33.41M
      ATLNAtlantic International Corporation
      $ 3.1674
      (50.11%)
      		615.54k
      BLNEEastside Distilling Inc
      $ 0.7237
      (-90.57%)
      		53.57k
      NVNINVNI Group Ltd
      $ 0.3798
      (-62.40%)
      		38.31M
      AGMHAGM Group Holdings Inc
      $ 0.1304
      (-60.32%)
      		9.47M
      PLRXPliant Therapeutics Inc
      $ 1.38
      (-59.88%)
      		19.51M
      AGHAureus Greenway Holdings Inc
      $ 2.23
      (-59.01%)
      		3.8M
      NVDANVIDIA Corporation
      $ 114.06
      (-8.69%)
      		409.42M
      BTOGBit Origin Ltd
      $ 0.3209
      (76.32%)
      		291.2M
      FTFTFuture FinTech Group Inc
      $ 0.249
      (23.27%)
      		218.59M
      SPGCSacks Parente Golf Inc
      $ 0.187
      (-10.35%)
      		160.53M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 12.6667
      (-5.82%)
      		153.57M

      BDSX Discussion

      View Posts
      georgie18 georgie18 2 months ago
      BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      Mr Schuler is buying shares again
      👍️0
      tw0122 tw0122 4 months ago
      Is selling $250 million in stock fro time to time on the downside.. Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.
      👍️0
      tw0122 tw0122 4 months ago
      Lung diagnostics cancer revenues improving still has $33m cash $1.49 +'14%
      👍️0
      AJ Freely AJ Freely 2 years ago
      $BDSX - Up 12%/ Current Price $1.34.
      Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
      👍️0
      1hot toddy 1hot toddy 2 years ago
      WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

      3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$
      👍️0
      Leg58 Leg58 2 years ago
      Lots if potential but will public offering dilute price?
      👍️0
      Leg58 Leg58 2 years ago
      Lots if potential but will public offering dilute price?
      👍️0
      subslover subslover 2 years ago
      Earnings look good.
      👍️0
      subslover subslover 2 years ago
      Earnings look good.
      👍️0
      MiamiGent MiamiGent 2 years ago
      BDSX Has news this morning!

      The contract covers the company’s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGS™ testing.

      https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

      https://stockcharts.com/h-sc/ui?s=BDSX
      👍️0
      carusso carusso 2 years ago
      Not so much...
      👍️0
      crudeoil24 crudeoil24 2 years ago
      LET'S GO BDSX !!!!!
      👍️0
      crudeoil24 crudeoil24 2 years ago
      Biodesix to Participate in Two Upcoming Investor Conferences in September
      6:00 am ET September 6, 2022 (BusinessWire) Print
      Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

      Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

      H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY
      👍️0
      crudeoil24 crudeoil24 2 years ago
      Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
      👍️0
      Leg58 Leg58 3 years ago
      US based company is quietly trending up. IMHO.
      GLTA
      👍️0

      Your Recent History

      NASDAQ
      BDSX
      Biodesix
      BIT
      MBG
      MercedesBenz
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads